Allspring Global Investments
COLL icon

Allspring Global Investments’s Collegium Pharmaceutical COLL Stock Holding History

Allspring Global Investments’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$334K Buy
9,324
+292
+3% +$9.98K ﹤0.01% 1551
2026
Q1 		$300K Buy
9,032
+924
+11% +$39.1K ﹤0.01% 1527
2025
Q4 		$369K Buy
8,108
+718
+10% +$30K ﹤0.01% 1462
2025
Q3 		$260K Sell
7,390
-73
-1% -$2.54K ﹤0.01% 1513
2025
Q2 		$226K Sell
7,463
-717
-9% -$20.5K ﹤0.01% 1524
2025
Q1 		$244K Buy
+8,180
New +$250K ﹤0.01% 1621
2024
Q4 		– Sell
-79,822
Closed -$3.08M – 1912
2024
Q3 		$3.08M Buy
79,822
+36,331
+84% +$1.3M ﹤0.01% 1065
2024
Q2 		$1.4M Sell
43,491
-1,947
-4% -$67.5K ﹤0.01% 1254
2024
Q1 		$1.76M Sell
45,438
-424
-0.9% -$14.8K ﹤0.01% 1223
2023
Q4 		$1.41M Buy
45,862
+4,192
+10% +$105K ﹤0.01% 1254
2023
Q3 		$931K Buy
41,670
+37,946
+1,019% +$865K ﹤0.01% 1380
2023
Q2 		$80K Buy
3,724
+1,182
+46% +$26.8K ﹤0.01% 2140
2023
Q1 		$61K Buy
2,542
+581
+30% +$15.4K ﹤0.01% 2220
2022
Q4 		$45.5K Sell
1,961
-43
-2% -$867 ﹤0.01% 2359
2022
Q3 		$32K Buy
2,004
+245
+14% +$4.32K ﹤0.01% 2494
2022
Q2 		$31K Sell
1,759
-64,158
-97% -$1.08M ﹤0.01% 2385
2022
Q1 		$1.34M Sell
65,917
-15,142
-19% -$286K ﹤0.01% 1723
2021
Q4 		$1.51M Buy
+81,059
New +$1.58M ﹤0.01% 1692

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Allspring Global Investments's COLL Position: Q2 2026 in Review

Allspring Global Investments increased its Collegium Pharmaceutical (COLL) stake by 3.2% in Q2 2026, buying an estimated $9.98K and bringing the position to 9,324 shares worth $334K. The position accounts for ﹤0.01% of the portfolio, ranked #1551.

Allspring Global Investments first reported a position in COLL in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.08M in Q3 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Allspring Global Investments held 9,324 shares of Collegium Pharmaceutical worth $334K as of Q2 2026.
  • Allspring Global Investments bought 292 Collegium Pharmaceutical shares in Q2 2026, an estimated $9.98K.
  • Collegium Pharmaceutical made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1551 holding.
  • Allspring Global Investments first reported a position in Collegium Pharmaceutical in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's Collegium Pharmaceutical position peaked at $3.08M in Q3 2024.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.